On November 13, Gelonghui reported that Sailun Biotech (688163.SH) stated on the interactive platform that the company has conducted research and development planning for new snake venom antivenom drugs and new products for rapid snake venom diagnosis based on years of accumulated research on snake venom toxins, technological advantages, and ongoing investment, with some projects already in the clinical research stage.
赛伦生物(688163.SH)：在抗蛇毒血清新药研发、蛇毒快速诊断试剂系列新产品上进行了研发布局
Selon Biological (688163.SH): has launched research on new drugs for anti-snake venom serum, as well as a series of new products for rapid snake venom diagnosis reagents.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha